Magdalena holds an MSc in Pharmaceutical Bioscience and an interdisciplinary PhD merging the fields of psychiatry, immunology and neuropharmacology. Her previous research focused on metabolic and immunologic changes in psychotic disorders. She is now focusing on science writing, allowing her to culture her passion for medical science and human health.
Nonalcoholic steatohepatitis, or NASH, might be prevented by treatments able to target certain immune cells, according to a recent study in mice which demonstrated that the condition has an inflammatory basis. Researchers ... Read more
Cerenis Therapeutics has initiated a Phase 1 clinical trial of CER-209 for the treatment of non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD). The drug is a compound ... Read more
A compound found in broccoli sprouts apparently prevents obesity and fatty liver disease by boosting the amount of brown fat and improving the composition of gut bacteria linked to a high-fat ... Read more
Researchers show that the effects of a single high-fat meal alters the sensitivity to insulin and changes liver metabolism in a way that may be the first step toward ... Read more